D
Daniel Aletaha
Researcher at Medical University of Vienna
Publications - 398
Citations - 51111
Daniel Aletaha is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Rheumatoid arthritis & Medicine. The author has an hindex of 74, co-authored 298 publications receiving 43215 citations. Previous affiliations of Daniel Aletaha include National Institutes of Health & University of Vienna.
Papers
More filters
Journal ArticleDOI
Different Rating of Global Rheumatoid Arthritis Disease Activity in Rheumatoid Arthritis Patients With Multiple Morbidities.
Helga Radner,Kazuki Yoshida,Sara K. Tedeschi,Paul Studenic,Michelle L. Frits,Christine Iannaccone,Nancy A. Shadick,Michael E. Weinblatt,Daniel Aletaha,Josef S Smolen,Daniel H. Solomon +10 more
TL;DR: To quantify differences and determine the factors contributing to the difference in patient global assessment of rheumatoid arthritis (RA) disease activity (PtGA) between RA patients with multiple morbidities (RA‐MM) and those with RA only, a comparison study is conducted.
Journal ArticleDOI
2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice
Valentin Ritschl,Tanja Stamm,Daniel Aletaha,Johannes W. J. Bijlsma,Peter Böhm,Razvan Dragoi,Emma Dures,Fernando Estévez-López,Laure Gossec,Annamaria Iagnocco,Andréa Marques,E. Moholt,Michal Nudel,Bart J F van den Bemt,Kirsten K. Viktil,Marieke Voshaar,Annette de Thurah,Loreto Carmona +17 more
TL;DR: In this paper, an EULAR task force was established to establish points to consider (PtCs) for the prevention, screening, assessment and management of non-adherence to (non-)pharmacological treatments in people with rheumatic and musculoskeletal diseases.
Journal ArticleDOI
Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review
TL;DR: Several predictors of successful bDMARD discontinuation were identified, and although studies are heterogeneous, these predictors may inform clinical decision making in patients who are considered for a potential bDMARDS discontinuation.
Journal ArticleDOI
Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis
Irina Gessl,Mihaela Popescu,Victoria Schimpl,G. Supp,Thomas Deimel,Martina Durechova,Miriam Hucke,Michaela Loiskandl,Paul Studenic,Michael Zauner,Josef S Smolen,Daniel Aletaha,Peter Mandl +12 more
TL;DR: In this paper, a binary damage score (positive if ≥ 1 erosion, joint space narrowing (JSN), osteophytes and malalignment) was calculated to determine whether clinical tenderness can be considered a sign of inflammatory joint activity.
Journal ArticleDOI
Compression test (Gaenslen's squeeze test) positivity, joint tenderness, and disease activity in patients with rheumatoid arthritis.
TL;DR: This work aimed to assess the factors related to a positive Gaenslen's test and to explore differences in disease activity between GT‐positive and ‐negative patients.